Health
NIH ‘very concerned’ about serious side effect in coronavirus vaccine trial – FiercePharma
While the FDA weighs whether to resume its trial of AstraZeneca’s COVID-19 vaccine, which triggered a clinical hold last week after a U.K. patient was hit with a serious side effect, the NIH has launched its own study into the reaction—which could take up to…
The Food and Drug Administration (FDA) is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health (NIH) has launched an investigation of the case.
The highest levels of NIH are very concerned, said Avindra Nath, M.D., intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. Eve…
-
Noosa News18 hours agoThe Laundry Lady secures $1M to fuel international expansion
-
General23 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News15 hours agoHomicide investigation underway after woman found dead in north Brisbane
-
Noosa News15 hours agoTruffle growers say rare delicacy is worth its $3,500 per kilo expense